Drug intelligence / Profile preview

Biyan Tong

Development stage: Preclinical
Lead developer: the District Key Laboratory Fund of Longgang District of Shenzhen
Administration: Inhalation

Overview

Biyan Tong is a drug currently under investigation as a fumigation lotion for the treatment of allergic rhinitis. Clinical observations and mechanism studies are being conducted to evaluate its therapeutic effects. The development of Biyan Tong is supported by Shenzhen Hospital, Beijing University of Chinese Medicine and the District Key Laboratory Fund of Longgang District of Shenzhen.

Other names: Biyan Tong fumigation lotion

Beyond the preview

Go deeper on Biyan Tong.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biyan Tong.

Explore the full profile